Policymakers might find benefit in revisiting the assumptions underlying the program and in exploring other options to secure a more predictable and constrained pattern in #Medicaid prescription drug spending: https://t.co/2jW9jgtj8N
Seems like ages ago that the MDRP was a major point of debate. I enjoyed writing this piece then. Now I wonder if #COVID19 will reframe how we view Medicaid and how we pay for it. @JournalofEthics @VincentRK
Policymakers might find benefit in revisiting the assumptions underlying the Medicaid Drug Rebate Program and in exploring other options to secure a more predictable and constrained pattern in Medicaid prescription drug spending. @a_kaltenboeck https://t.c
"Regardless of whether or how they are implemented, closed formularies signal a deeper market challenge for brand-name drugs and reflect evolving demands on policies that aim to protect Medicaid by leveraging other payers." https://t.co/DoeJKRrDux